These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30171556)

  • 21. In vitro selection of BNA (LNA) aptamers.
    Kuwahara M; Obika S
    Artif DNA PNA XNA; 2013; 4(2):39-48. PubMed ID: 24044051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
    Errington SJ; Mann CJ; Fletcher S; Wilton SD
    J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and properties of 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides.
    Morita K; Takagi M; Hasegawa C; Kaneko M; Tsutsumi S; Sone J; Ishikawa T; Imanishi T; Koizumi M
    Bioorg Med Chem; 2003 May; 11(10):2211-26. PubMed ID: 12713831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.
    Takeshima Y; Yagi M; Matsuo M
    Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and properties of 2'-O,4'-C-spirocyclopropylene bridged nucleic acid (scpBNA), an analogue of 2',4'-BNA/LNA bearing a cyclopropane ring.
    Yamaguchi T; Horiba M; Obika S
    Chem Commun (Camb); 2015 Jun; 51(47):9737-40. PubMed ID: 25985928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing system.
    Malueka RG; Yagi M; Awano H; Lee T; Dwianingsih EK; Nishida A; Takeshima Y; Matsuo M
    Nucleic Acid Ther; 2011 Oct; 21(5):347-53. PubMed ID: 21967521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational Design of Short Locked Nucleic Acid-Modified 2'-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro.
    Le BT; Adams AM; Fletcher S; Wilton SD; Veedu RN
    Mol Ther Nucleic Acids; 2017 Dec; 9():155-161. PubMed ID: 29246294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 2'-O-(N-methylcarbamoylethyl) 5-methyl-2-thiouridine and its application to splice-switching oligonucleotides.
    Masaki Y; Yamamoto K; Inde T; Yoshida K; Maruyama A; Nagata T; Tanihata J; Takeda S; Sekine M; Seio K
    Bioorg Med Chem Lett; 2019 Jan; 29(2):160-163. PubMed ID: 30551900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of exon skipping activity by reduction in the secondary structure content of LNA-based splice-switching oligonucleotides.
    Shimo T; Tachibana K; Kawawaki Y; Watahiki Y; Ishigaki T; Nakatsuji Y; Hara T; Kawakami J; Obika S
    Chem Commun (Camb); 2019 Jun; 55(48):6850-6853. PubMed ID: 31123731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biophysical properties of 5'-thio-2',4'-BNA/LNA oligonucleotide.
    Islam MA; Fujisaka A; Mori S; Ito KR; Yamaguchi T; Obika S
    Bioorg Med Chem; 2018 Jul; 26(12):3634-3638. PubMed ID: 29886084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and properties of 2',4'-BNA(NC): a bridged nucleic acid analogue.
    Rahman SM; Seki S; Obika S; Yoshikawa H; Miyashita K; Imanishi T
    J Am Chem Soc; 2008 Apr; 130(14):4886-96. PubMed ID: 18341342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamic and kinetic characterization of duplex formation between 2'-O, 4'-C-methylene-modified oligoribonucleotides, DNA and RNA.
    Christensen U
    Biosci Rep; 2007 Dec; 27(6):327-33. PubMed ID: 17592767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invention and Early History of Exon Skipping and Splice Modulation.
    Lim KRQ; Yokota T
    Methods Mol Biol; 2018; 1828():3-30. PubMed ID: 30171532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
    Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
    Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping.
    Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():165-171. PubMed ID: 30171541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.
    Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M
    Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action.
    Smith LD; Leme de Calais F; Raponi M; Mellone M; Buratti E; Blaydes JP; Baralle D
    Int J Cancer; 2017 Apr; 140(7):1564-1570. PubMed ID: 27997688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridged Nucleic Acids Reloaded.
    Soler-Bistué A; Zorreguieta A; Tolmasky ME
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31234313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
    Rodrigues M; Yokota T
    Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.